PPCBPropanc Biopharma, Inc.
Health Care
General and Administrative Expense revised down 99.8% for FY 2025
This is the 10th largest revision in PPCB's history.
General and Administrative Expense·FY 2025
Major restatement$109K▼ 99.8%
was$57M
Revised down in a S-1.
No amendment filed
As reported · Sep 30, 2025S-1 · Oct 6, 2026us-gaap:GeneralAndAdministrativeExpenseVerify against SEC filingsShow
As reported$57M
Accepted 2025-09-300001493152-25-016069
Restated$109K
Accepted 2026-10-060001493152-26-045770
GeneralAndAdmin · reported 5 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time PPCB — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.